Scientists are rapidly investigating retatrutide, a novel drug created by Eli Lilly, as a potential step in weight loss . Different than many existing approaches, retatrutide is a double -action compound targeting both GLP-1 and GIP, substances that influence appetite and blood sugar balance. Pr… Read More